Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
SC Proposes Rate Cuts for Some Credit Property Insurance South Carolina’s Department of Insurance plans to cut the rates for some credit property insurance, which lenders sometimes require to protect...
States Eying Higher Electricity Rates for Data Centers At least a dozen states are considering ways to make data centers pay more for their power, with evidence mounting that data center demand is driving...
Evers Vetoes Insurance Reg Exemption for Direct Primary Care Doctors Wisconsin Gov. Tony Evers (D) vetoed a bill ( SB 4 ) that would have exempted primary care doctors who provide care to patients who...
A few months ago we reported on state legislation targeting “predictive pricing,” the use of “data analytics, machine learning and algorithms to anticipate market demand and adjust prices...
CA Regulators Complete Review of Wildfire Risk Model California’s Department of Insurance has completed a review of the state’s first wildfire catastrophe model, which property/casualty insurers...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
A bill (SB 410) debated in the Michigan Senate last week would allow residents and state and local governments to sue drug manufacturers and sellers if their products cause injury. In 1995 the state passed the strongest drug immunity law in the nation, shielding drugmakers and sellers almost entirely from such suits. (BRIDGE MICHIGAN)
This year at least 24 states have enacted legislation dealing with health system consolidation and competition, according to the National Conference of State Legislatures. Among many other things the measures address the review and approval of health system mergers, reforms of health system contracting and certificate of need review. (NCSL)
California Gov. Gavin Newsom vetoed a bill (SB 90) that would have prohibited insurers from charging consumers more than $35 out of pocket for a 30-day supply of insulin. Earlier this year the governor announced the state would be partnering with the nonprofit pharmaceutical company Civica Rx to produce its own insulin, which it plans to sell for $30. (ASSOCIATED PRESS, STATE NET)
American taxpayers are overpaying for Medicare Advantage, or Medicare Part C—under which insurance companies are paid by the federal government to manage patient care—by at least $88 billion per year and possibly as much as $140 billion per year, according to a report published by Physicians for a National Health Program. “Various elements of MA, either by design or by consequence, result in a much higher level of government spending than is necessary to provide Medicare benefits, with much of this money going toward corporate profits,” the report states. (MEDICAL ECONOMICS)
—Compiled by SNCJ Managing Editor KOREY CLARK